Tag: ACC.21

Vascular News’ top 10 most popular stories of May 2021

Expanding eligibility for endovascular aneurysm repair (EVAR), new tools for chronic limb-threatening ischaemia (CLTI), and promising data for arteriovenous (AV) fistula remote monitoring all...

ACC 2021: VOYAGER-PAD analysis shows totality of ischaemic events reduced following...

Rupert Bauersachs (Darmstadt, Germany) talks to Cardiovascular News about the VOYAGER-PAD trial, the results of which he presented at the American College of Cardiology’s...

ACC.21: VOYAGER PAD analysis shows reduced risk of ischaemic events in...

Rivaroxaban (Xarelto, Bayer/Janssen), in addition to low-dose aspirin, should be considered as an adjunctive therapy after lower extremity revascularisation to reduce first and subsequent...